Zanamivir overdosage: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 5: | Line 5: | ||
==Overdosage== | ==Overdosage== | ||
There have been no reports of overdosage from administration of RELENZA.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf | publisher = |date = | accessdate = }}</ref> | There have been no reports of overdosage from administration of RELENZA.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf | publisher = |date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
| Line 12: | Line 11: | ||
{{FDA}} | {{FDA}} | ||
[[Category: | [[Category:Antibiotics]] | ||
[[Category:Wikinfect]] | [[Category:Wikinfect]] | ||
Latest revision as of 23:54, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Overdosage
There have been no reports of overdosage from administration of RELENZA.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.